These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7030978)

  • 1. Comparative study of oxdralazine and dihydralazine in essential hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza W; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):372-6. PubMed ID: 7030978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antihypertensive activity of cadralazine (ISF 2469) and dihydralazine during chronic treatment.
    Strocchi E; Costa FV; Caldari R; Malini PL; Marata AM; Parini J; Ambrosioni E
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):519-23. PubMed ID: 6642790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term study of oxdralazine in hypertensive patients.
    Salvadeo A; Villa G; Segagni S; Criscuolo D
    Arzneimittelforschung; 1979; 29(11):1753-5. PubMed ID: 396926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hypertension with obsilazin].
    Sirakova V; Penkov N; Kaponov Kh; Dimitrov G
    Vutr Boles; 1986; 25(2):32-6. PubMed ID: 2872755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension].
    Levenson J; Simon A; Achimastos A; Temmar M; Safar M
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
    Wacker JR; Wagner BK; Briese V; Schauf B; Heilmann L; Bartz C; Hopp H
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):160-5. PubMed ID: 16253414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crossover trial of oxdralazine in hypertension.
    Salvadeo A; Villa G; Segagni S; Galli F; Criscuolo D
    J Clin Pharmacol; 1983 Apr; 23(4):155-60. PubMed ID: 6345596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydralazine therapy and acetylator phenotype.
    Iisalo E; Laine T; Lehtonen A; Sellman R
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effect of prizidilol.
    Jounela AJ; Honkala M; Huikuri H
    Ann Clin Res; 1984; 16(3):176-80. PubMed ID: 6383185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy.
    Lammintausta R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):581-4. PubMed ID: 365799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
    Widimský J; Balazovjech I; Lánská V
    Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
    Moskowitz RM; Cohn JN
    Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
    Thibonnier M; Lardoux MD; Corvol P
    Br J Clin Pharmacol; 1980 Jun; 9(6):561-7. PubMed ID: 6992823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A cross-over comparison of dihydralazine and minoxidil in severe hypertension (author's transl)].
    Rumboldt Z; Jurisić M; Bagatin J
    Lijec Vjesn; 1982 Feb; 104(2):64-8. PubMed ID: 7050574
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
    J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.